Ludwig cancer research study shows how novel drug screen can individualize cancer therapy
(Ludwig Institute for Cancer Research) A study conducted by researchers at the Ludwig Center at Harvard has demonstrated how a drug screening method known as dynamic BH3 profiling can be used to quickly identify potentially effective combinations of existing drugs for personalized cancer therapy.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Therapy | Harvard | International Medicine & Public Health | Study